Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial

JOURNAL ARTICLE published March 2016 in Annals of Oncology

Authors: D. Lorusso | G. Scambia | S. Pignata | R. Sorio | G. Amadio | S. Lepori | A. Mosconi | C. Pisano | G. Mangili | G. Maltese | R. Sabbatini | G. Artioli | T. Gamucci | M. Di Napoli | E. Capoluongo | V. Ludovini | F. Raspagliesi | G. Ferrandina